Family Legacy Inc. Lowers Stock Position in National Health Investors, Inc. (NYSE:NHI)

Family Legacy Inc. cut its holdings in shares of National Health Investors, Inc. (NYSE:NHI) by 30.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 9,603 shares of the real estate investment trust’s stock after selling 4,300 shares during the period. Family Legacy Inc.’s holdings in National Health Investors were worth $536,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of NHI. Lazard Asset Management LLC purchased a new position in National Health Investors in the 2nd quarter valued at $32,000. Advisory Services Network LLC lifted its holdings in National Health Investors by 71.8% in the first quarter. Advisory Services Network LLC now owns 737 shares of the real estate investment trust’s stock valued at $38,000 after acquiring an additional 308 shares during the period. International Assets Investment Management LLC acquired a new stake in National Health Investors in the third quarter valued at $38,000. Sound Income Strategies LLC lifted its holdings in National Health Investors by 33.5% in the fourth quarter. Sound Income Strategies LLC now owns 916 shares of the real estate investment trust’s stock valued at $51,000 after acquiring an additional 230 shares during the period. Finally, State of Wyoming lifted its holdings in National Health Investors by 199.3% in the fourth quarter. State of Wyoming now owns 1,242 shares of the real estate investment trust’s stock valued at $65,000 after acquiring an additional 827 shares during the period. 62.14% of the stock is currently owned by hedge funds and other institutional investors.

National Health Investors Price Performance

NHI stock traded down $0.05 during trading on Tuesday, hitting $61.57. The stock had a trading volume of 154,775 shares, compared to its average volume of 176,279. The company has a debt-to-equity ratio of 0.90, a quick ratio of 10.27 and a current ratio of 10.27. The stock has a market cap of $2.67 billion, a price-to-earnings ratio of 19.67 and a beta of 0.94. The company’s 50 day moving average price is $56.44 and its two-hundred day moving average price is $54.17. National Health Investors, Inc. has a 1-year low of $47.54 and a 1-year high of $62.30.

National Health Investors Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 3rd. Shareholders of record on Thursday, March 28th will be issued a $0.90 dividend. This represents a $3.60 annualized dividend and a yield of 5.85%. The ex-dividend date of this dividend is Wednesday, March 27th. National Health Investors’s dividend payout ratio (DPR) is 115.02%.

Insider Buying and Selling at National Health Investors

In other National Health Investors news, Director Charlotte A. Swafford purchased 10,000 shares of the stock in a transaction on Tuesday, February 27th. The stock was bought at an average price of $58.69 per share, for a total transaction of $586,900.00. Following the acquisition, the director now directly owns 110,185 shares of the company’s stock, valued at $6,466,757.65. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. 7.26% of the stock is owned by company insiders.

Analysts Set New Price Targets

NHI has been the subject of a number of recent analyst reports. Deutsche Bank Aktiengesellschaft initiated coverage on National Health Investors in a report on Tuesday, January 30th. They issued a “buy” rating and a $69.00 target price for the company. StockNews.com raised National Health Investors from a “hold” rating to a “buy” rating in a research note on Monday. BMO Capital Markets raised National Health Investors from a “market perform” rating to an “outperform” rating and set a $67.00 price target for the company in a research note on Tuesday, March 12th. Wells Fargo & Company raised National Health Investors from an “equal weight” rating to an “overweight” rating and lifted their price target for the stock from $55.00 to $63.00 in a research note on Monday, February 26th. Finally, Stifel Nicolaus reaffirmed a “hold” rating and set a $55.00 price target on shares of National Health Investors in a research note on Tuesday, November 28th. Four analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $59.22.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.